Trial Profile
A Phase 2a, Single-Center, Randomized, Double-Blind, Double- Dummy, Placebo- and Active-Controlled Analgesic Study of an Oral Dose of V117957 4.5 mg for the Treatment of Postsurgical Pain Due to Third Molar Extraction
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2013
Price :
$35
*
At a glance
- Drugs Sunobinop (Primary) ; Ibuprofen
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- 01 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Jul 2013 New trial record